EYPT vs GEN · rev $1.2M vs P/E 17, rev $5.00B
Eyepoint Pharmaceuticals Inc (EYPT) versus Gen Digital Inc. (GEN) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
EYPT currently screens at market cap $1.10B. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Not investment advice. Open the EYPT and GEN stock pages for the full models.
Not investment advice.